This topic contains a solution. Click here to go to the answer

Author Question: Which of the following has not been a major contributor to the growth of medical-care costs in the ... (Read 115 times)

hbsimmons88

  • Hero Member
  • *****
  • Posts: 526
Which of the following has not been a major contributor to the growth of medical-care costs in the states over the past two decades?
 
  a. The increased costs of hospitalization, which have risen faster than general inflation
  b. The increased costs of prescription drugs, which have risen faster than general inflation
  c. The rapid growth of Health Maintenance Organizations (HMOs) as providers of managed health care
  d. The increased reliance on third-party payers of health care costs

Question 2

Which is true of the Medicaid program?
 
  a. States pay the majority of benefit costs.
  b. The federal government pays 90 percent of the costs.
  c. Medicaid lion's share of the cost of benefits goes largely to families receiving TANF.
  d. None of the above is true.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

k2629

  • Sr. Member
  • ****
  • Posts: 357
Answer to Question 1

c

Answer to Question 2

d





 

Did you know?

During the twentieth century, a variant of the metric system was used in Russia and France in which the base unit of mass was the tonne. Instead of kilograms, this system used millitonnes (mt).

Did you know?

Oliver Wendell Holmes is credited with introducing the words "anesthesia" and "anesthetic" into the English language in 1846.

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library